Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246320 · ClinicalTrials.gov registry record · NA
Taking Brain Monitoring to the Next Level
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04246320 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 7 participants.
The verdict
NCT04246320, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This one arm clinical study will assess the impact of a goal directed therapy intervention, aiming at optimizing depth of anesthesia and intraoperative blood pressure on the incidence of postoperative cognitive dysfunction and delirium relative to a standardized anesthetic plan. We will enroll 60 patients and will measure the neurocognitive status (MoCA test) of patients before and after surgery (at discharge, within 2 weeks after surgery and 6 months after surgery) to determine the relative impact of anesthetic care on the development of postoperative delirium and cognitive decline. All patients will have a brain scan (fMRI) before and after surgical intervention. Patients will also be asked to participate in an optional blood draw which will take place during their brain imaging visit and post operatively (within 2 days after surgery).
Interventions
- OTHER Goal directed therapy (GDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2022-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04246320
The ClinicalTrials.gov registry entry for NCT04246320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Goal directed therapy (GDT) is the first listed.
NCT04246320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04246320 about?
NCT04246320 is a clinical study titled "Taking Brain Monitoring to the Next Level". This one arm clinical study will assess the impact of a goal directed therapy intervention, aiming at optimizing depth of anesthesia and intraoperative blood pressure on the incidence of postoperative cognitive dysfunction and delirium relative to a standardized anesthetic plan. We will enroll 60 pa...
What is the current status of trial NCT04246320?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2020-01-30. Estimated completion is 2022-08-13.
What interventions are being tested in trial NCT04246320?
The interventions under investigation include: Goal directed therapy (GDT) (OTHER).
Who is sponsoring clinical trial NCT04246320?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.